Iceland· IS-EU/1/23/1756/001
Inaqovi
A decitabin, kombinationen product containing decitabinum inn,cedazuridine, registered in Iceland by Otsuka Pharmaceutical Netherlands B.V.*. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Decitabin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC L01BC58 (decitabin, kombinationen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Decitabin, kombinationen · ATC L01BC58
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Decitabinum INN,CEDAZURIDINE
- Manufacturer
- Otsuka Pharmaceutical Netherlands B.V.*
- Country
- Iceland (IS)
- ATC code
- L01BC58
- ATC class
- Decitabin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Decitabin, kombinationen in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaINQOVITAIHO PHARMA CANADA, INC.
- CzechiaINAQOVIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- SpainINAQOVI 35 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAOtsuka Pharmaceutical Netherlands B.V.
- FinlandInaqoviOtsuka Pharmaceutical Netherlands B.V.
- United KingdomInaqovi 35mg/100mg tabletsOtsuka Pharmaceuticals (U.K.) Ltd
- IrelandInaqovi 35 mg/100 mg film-coated tabletsOtsuka Pharmaceutical Netherlands B.V.
- NetherlandsInaqovi 35 mg/100, fimomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayInaqoviOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Inaqovi
- Norway · Inaqovi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47a345b3-88ca-4773-9a7f-7d9fde62e30c GET /v1/drugs/47a345b3-88ca-4773-9a7f-7d9fde62e30c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L01BC58",
"marketed": false,
"strength": "35mg/100 mg",
"ma_number": "EU/1/23/1756/001",
"substance": "Decitabinum INN,CEDAZURIDINE",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum og krabbameinslækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45184"
}See everything about decitabin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.